miR‐381‐3p attenuates doxorubicin resistance in human anaplastic thyroid carcinoma via targeting homeobox A9

Corresponding Author

Department of Head and Neck Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

Correspondence

Ke Li, Department of Head and Neck Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440 Jiyan Road, Jinan City 250117, Shandong Province, China.

Email: lili_ke2017@aliyun.com

Search for more papers by this author

留言 (0)

沒有登入
gif